{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:05:59Z","timestamp":1779944759792,"version":"3.53.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To isolate Parkinson\u2019s disease (PD)-specific gut dysbiosis from motility-related changes, this study compared the fecal microbiota of PD patients with constipation (PDC, n=20) against a functional constipation (FC, n=15) control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>High-throughput 16S rRNA gene sequencing and functional prediction were performed on fecal samples. Diversity metrics and taxonomic compositions were analyzed to identify PD-specific signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The PDC group exhibited significantly higher microbial richness than the FC group (P\u00a0=\u00a00.01). Despite structural similarities driven by the shared constipation phenotype (ANOSIM R\u00a0=\u00a00.084), PDC was distinguished by specific compositional shifts, including the enrichment of\n                      <jats:italic>Paraprevotella<\/jats:italic>\n                      ,\n                      <jats:italic>Akkermansia<\/jats:italic>\n                      ,\n                      <jats:italic>unclassified Ruminococcaceae<\/jats:italic>\n                      , and\n                      <jats:italic>Campylobacter<\/jats:italic>\n                      . Functionally, the PDC microbiome showed significant deficits in tyrosine and glutathione metabolism pathways (P&amp;lt;0.05), indicating compromised dopamine precursor synthesis and antioxidant defense.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By controlling for colonic transit time, this study identified specific microbial alterations and metabolic deficits in PD independent of constipation. These findings support a \u201cgut-first\u201d etiology linked to specific pathobionts and barrier compromise.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1767241","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:46:20Z","timestamp":1779943580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Specific gut microbiota alterations and metabolic deficits in Parkinson\u2019s disease: a controlled comparison with functional constipation"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Xuanwu Hospital Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Beijing Haidian Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xuanwu Hospital Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling the gut microbiota in Parkinson's disease: functional constipation as the perfect disease control","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s11596-021-2464-5","article-title":"Potential role of Akkermansia muciniphila in Parkinson's disease and other neurological\/autoimmune diseases","volume":"41","author":"Fang","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.871710","article-title":"Exploring the causal effect of constipation on Parkinson\u2019s disease through mediation analysis of microbial data","volume":"12","author":"Fu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI21468","article-title":"The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barr\u00e9 syndrome","volume":"114","author":"Godschalk","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1627406","article-title":"Efficacy of gut microbiota-targeted therapies in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Gu","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/metabo10090372","article-title":"Succinate is an inflammation-induced immunoregulatory metabolite in macrophages","volume":"10","author":"Harber","year":"2020","journal-title":"Metabolites"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.celrep.2019.10.035","article-title":"Integrated analyses of microbiome and longitudinal metabolome data reveal microbial-host interactions on sulfur metabolism in Parkinson\u2019s disease","volume":"29","author":"Hertel","year":"2019","journal-title":"Cell Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1654995","article-title":"Exploring gut microbiota alterations in Parkinson's disease: insights from a 16S amplicon sequencing Eastern European pilot study","volume":"19","author":"Ilie","year":"2025","journal-title":"Front. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.34133\/research.0846","article-title":"Gpr35 expression mitigates neuroinflammation and enriches gut Lactobacillus to relieve Parkinson's disease","volume":"8","author":"Meng","year":"2025","journal-title":"Res. (Washington D.C.)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1099\/ijs.0.008169-0","article-title":"Paraprevotella clara gen. nov., sp. nov. and Paraprevotella xylaniphila sp. nov., members of the family \u2018Prevotellaceae\u2019 isolated from human faeces","volume":"59","author":"Morotomi","year":"2009","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","article-title":"Meta-analysis of gut dysbiosis in Parkinson's disease","volume":"35","author":"Nishiwaki","year":"2020","journal-title":"Mov. Disord."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism","volume":"364","author":"Rekdal","year":"2019","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1038\/nmicrobiol.2016.93","article-title":"Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut","volume":"1","author":"Roager","year":"2016","journal-title":"Nat. Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson's disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jns.2015.06.028","article-title":"GM1 ganglioside in Parkinson's disease: results of a five-year open study","volume":"356","author":"Schneider","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","article-title":"Plasma short-chain fatty acids in patients with Parkinson\u2019s disease","volume":"35","author":"Shin","year":"2020","journal-title":"Mov. Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson's disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome-gut-brain axis in Parkinson disease \u2014 from basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","article-title":"Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates","volume":"65","author":"Vandeputte","year":"2016","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012289","article-title":"The interplay between gut microbiota and Parkinson's disease: implications on diagnosis and treatment","volume":"23","author":"Varesi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3748\/wjg.v30.i3.225","article-title":"Relationship among Parkinson\u2019s disease, constipation, microbes, and microbiological therapy","volume":"30","author":"Yuan","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114381","article-title":"Guillain-barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/gastro\/goab035","article-title":"Role of gut microbiota in functional constipation","volume":"9","author":"Zhang","year":"2021","journal-title":"Gastroenterol. Rep. (Oxf)"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1767241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:46:32Z","timestamp":1779943592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1767241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":31,"alternative-id":["10.3389\/fcimb.2026.1767241"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1767241","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1767241"}}